Robert Young Kim 4 D Molecular Therapeutics, Inc. (FDMT) insider trading activity

FDMT Quotes by TradingView

Robert Young Kim is Chief Medical Officer of 4D Molecular Therapeutics, Inc.. Currently has a direct ownership of 1,043 shares of FDMT, which is worth approximately $5,788. The most recent transaction as insider was on Feb 05, 2024, when has been sold 24,552 shares (Common Stock) at a price of $30.05 per share, resulting in proceeds of $737,787. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.04K
0% 3M change
n/a 12M change
Total Value Held $5,788

Robert Young Kim Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 05 2024
SELL
Open market or private sale
$737,787 $30.05 p/Share
24,552 Reduced 95.92%
1,043 Common Stock
Feb 05 2024
BUY
Exercise of conversion of derivative security
$339,840 $14.16 p/Share
24,000 Added 75.96%
7,595 Common Stock
RYK

Robert Young Kim

Chief Medical Officer
Emeryville, CA

Track Institutional and Insider Activities on FDMT

Follow 4D Molecular Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FDMT shares.

Notify only if

Insider Trading

Get notified when an 4 D Molecular Therapeutics, Inc. insider buys or sells FDMT shares.

Notify only if

News

Receive news related to 4D Molecular Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FDMT